JP2021530543A5 - - Google Patents
Info
- Publication number
- JP2021530543A5 JP2021530543A5 JP2021503571A JP2021503571A JP2021530543A5 JP 2021530543 A5 JP2021530543 A5 JP 2021530543A5 JP 2021503571 A JP2021503571 A JP 2021503571A JP 2021503571 A JP2021503571 A JP 2021503571A JP 2021530543 A5 JP2021530543 A5 JP 2021530543A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- patient
- riluzole
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025026643A JP2025093952A (ja) | 2018-07-22 | 2025-02-21 | アルツハイマー病を処置するためのリルゾールプロドラッグの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862701814P | 2018-07-22 | 2018-07-22 | |
| US62/701,814 | 2018-07-22 | ||
| PCT/US2019/042718 WO2020023324A1 (en) | 2018-07-22 | 2019-07-20 | Use of riluzole prodrugs to treat alzheimer's disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025026643A Division JP2025093952A (ja) | 2018-07-22 | 2025-02-21 | アルツハイマー病を処置するためのリルゾールプロドラッグの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021530543A JP2021530543A (ja) | 2021-11-11 |
| JP2021530543A5 true JP2021530543A5 (cg-RX-API-DMAC7.html) | 2022-02-15 |
Family
ID=69181140
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503571A Pending JP2021530543A (ja) | 2018-07-22 | 2019-07-20 | アルツハイマー病を処置するためのリルゾールプロドラッグの使用 |
| JP2025026643A Pending JP2025093952A (ja) | 2018-07-22 | 2025-02-21 | アルツハイマー病を処置するためのリルゾールプロドラッグの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025026643A Pending JP2025093952A (ja) | 2018-07-22 | 2025-02-21 | アルツハイマー病を処置するためのリルゾールプロドラッグの使用 |
Country Status (14)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL299301A (en) * | 2020-06-24 | 2023-02-01 | Biohaven Therapeutics Ltd | Compositions and methods for the treatment of obsessive compulsive disorder |
| EP4240308A4 (en) * | 2020-10-05 | 2024-10-30 | Icahn School of Medicine at Mount Sinai | Riluzole for the treatment of alzheimer's disease |
| WO2022155564A1 (en) * | 2021-01-18 | 2022-07-21 | Biohaven Therapeutics Ltd. | Use of riluzole prodrugs to treat alzheimer's disease |
| BR112023016690A2 (pt) * | 2021-02-22 | 2023-11-14 | Univ Yale | Degradadores bifuncionais direcionados e métodos usando os mesmos |
| CN114344297B (zh) * | 2022-03-01 | 2024-05-14 | 暨南大学 | 利鲁唑在治疗少精症中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001275525B2 (en) * | 2000-06-14 | 2007-04-26 | Medarex, Inc. | Tripeptide prodrug compounds |
| EP1814558B1 (en) * | 2004-11-01 | 2010-12-15 | Seo Hong Yoo | Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
| FR2957077B1 (fr) * | 2010-03-02 | 2012-04-13 | Univ Dauvergne Clermont I | Utilisation du riluzole pour traiter ou prevenir les effets indesirables d'agents anti-cancereux |
| WO2015089049A1 (en) | 2013-12-09 | 2015-06-18 | Thomas Jefferson University | Novel methods of treating a neurodegenerative disease in a mammal in need thereof |
| US10258611B2 (en) * | 2014-11-26 | 2019-04-16 | Medicinova, Inc. | Combination of ibudilast and riluzole and methods of using same |
| DK3265448T3 (da) * | 2015-03-03 | 2022-03-28 | Biohaven Therapeutics Ltd | Riluzol-prodrugs og anvendelse deraf |
| HRP20220237T1 (hr) * | 2016-05-20 | 2022-04-29 | Biohaven Therapeutics Ltd. | Primjena riluzola, prolijekova riluzola ili analoga riluzola sa imunoterapijama za liječenje raka |
| US12029731B2 (en) * | 2016-08-10 | 2024-07-09 | Biohaven Therapeutics Ltd. | Acyl benzo[d]thiazol-2-amine and their methods of use |
| US10751345B2 (en) * | 2018-02-21 | 2020-08-25 | AI Therapeutics, Inc. | Combination therapy with apilimod and glutamatergic agents |
| WO2022155564A1 (en) * | 2021-01-18 | 2022-07-21 | Biohaven Therapeutics Ltd. | Use of riluzole prodrugs to treat alzheimer's disease |
-
2019
- 2019-07-20 JP JP2021503571A patent/JP2021530543A/ja active Pending
- 2019-07-20 US US17/261,057 patent/US12161633B2/en active Active
- 2019-07-20 KR KR1020217004639A patent/KR20210034621A/ko not_active Ceased
- 2019-07-20 AU AU2019310013A patent/AU2019310013B2/en active Active
- 2019-07-20 WO PCT/US2019/042718 patent/WO2020023324A1/en not_active Ceased
- 2019-07-20 CA CA3107215A patent/CA3107215A1/en active Pending
- 2019-07-20 BR BR112021000768-7A patent/BR112021000768A2/pt unknown
- 2019-07-20 EP EP19841953.3A patent/EP3823616A4/en active Pending
- 2019-07-20 IL IL280177A patent/IL280177B2/en unknown
- 2019-07-20 CN CN201980048687.7A patent/CN112469408A/zh active Pending
- 2019-07-20 EA EA202190308A patent/EA202190308A1/ru unknown
- 2019-07-20 MX MX2021000515A patent/MX2021000515A/es unknown
- 2019-07-20 SG SG11202100385YA patent/SG11202100385YA/en unknown
-
2021
- 2021-01-07 PH PH12021550043A patent/PH12021550043A1/en unknown
- 2021-01-14 MX MX2024010655A patent/MX2024010655A/es unknown
-
2025
- 2025-02-21 JP JP2025026643A patent/JP2025093952A/ja active Pending